Autosomal Dominant Polycystic Kidney Disease " Understanding the Disease and Improving Treatment Adherence and Outcome

Access Activity

Overview / Abstract:

Target Audience
This activity is designed to meet the educational needs of nephrologists, primary care providers, and providers who care for patients with kidney disease.

Program Overview
In the real-world setting, treatment adherence in patients with autosomal dominant polycystic kidney disease (ADPKD) can be a challenge. This CME program will discuss the diagnosis and management of ADPKD as well as strategies on improving treatment adherence. Patients’ perspectives on how to deal with aquaresis-related symptoms will be shared.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Recognize the problem of lack of adherence to therapy in patients with ADPKD in the real-world.
Identify barriers for treatment initiation and risk for treatment discontinuation in clinical practice.
Develop evidence-based strategies to counter the aquaretic effect from disease modifying therapy.

Expiration

Jun 30, 2025

Discipline(s)

Nursing CNE, Physician CME

Format

Online

Credits / Hours

1.0 AMA PRA Category 1 Credit(s)

Accreditation

ACCME, ANCC

Presenters / Authors / Faculty

Faculty
Neera Dahl, MD PhD
Neera Dahl, MD PhD
Dr. Dahl is a nephrologist and the Director of the PKD Foundation Center of Excellence at Mayo Clinic, Rochester, MN. She is a nationally recognized expert in the field of autosomal dominant polycystic kidney disease (ADPKD).

Navin Gupta, MD
Navin Gupta, MD
Dr. Gupta is a nephrologist at Mayo Clinic, Rochester, MN. He has extensive experience in the diagnosis and management of ADPKD. His translational research work is supported by the National Institute of Health.

Navin Gupta, MD
Elyssa Noce, DNP, APRN
Dr. Noce is a nephrology nurse practitioner at Yale-New Haven Hospital in New Haven, CT, where provides care for patients across the spectrum of renal diseases. She is a core member of the PKD Foundation Center of Excellence program at Yale, where she provides expertise in the holistic care of patients with ADPKD, including patient counseling and medication management. She is also a lecturer in the master’s program at Yale University.

Sponsors / Supporters / Grant Providers

Otsuka Pharmaceuticals.

Keywords / Search Terms

Relias LLC Relias LLC., FreeCME., Autosomal Dominant Polycystic Kidney Disease, Polycystic Kidney Disease Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map